10 Dec, 2024 Life Sciences News in Italy: November 2024 By DLA Piper Life Sciences Regulatory MDCG updates Q&A on vigilance terms under MDR and IVDR On 11 November 2024, the Medical Device Coordination Group (MDCG)...
30 Sep, 2024 A New Era of Pay Transparency is Here By Katie Davies In recent years, there has been an upward global trend in the implementation of new legal measures aimed at addressing pay transparency....
11 Sep, 2024 Navigating EU and national regulatory scrutiny in so called “killer acquisitions” By Alexandra Kamerling Darach Connolly Zoltan Marosi Daniel Colgan Amanda Wait +2 more... Show less The implications of the recent Illumina/Grail Judgment Executive Summary In a landmark EU judgment, on 3 September 2024, the Court of...
09 Sep, 2024 Life Sciences News in Italy: August 2024 By DLA Piper Life Sciences Regulatory AIFA updates Guidelines for the classification and conduct of observational studies on medicines On 20 August 2024, the...
04 Sep, 2024 Poland - Life Sciences Monthly Brief, August 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
22 Apr, 2024 Portugal implements Regulation (EU) 2017/745, on Medical Devices By Inês Santana Metello Mariana Ricardo It has been just over three years since the respective notification procedure to the European Commission (reported here), the Portuguese...
08 Jan, 2024 Portugal | Removal of the retail price of medicines from labelling and packaging By Mariana Ricardo Since 2006, when the Medicines Code was approved in Portugal, marketing authorisation holders had to include the retail selling price of...
23 Nov, 2023 UK CMA publishes Competition Law Guidance for Cooperations on Combination Therapies By Alexandra Kamerling Executive Summary Combination therapies involve the use of two or more separate medicines in combination to treat a disease. It can be...
17 Nov, 2023 UK Healthcare Procurement: Provider selection regime regulations overview By Sammi King Saman Anwar Mark Vipan It is currently intended that the Provider Selection Regime (PSR) will come into force on 1 January 2024. The PSR Regulations are a new...
25 Oct, 2023 Artificial Intelligence and healthcare: the Italian DPA adopts a decalogue on GDPR compliance of national healthcare services using AI By Cristina Criscuoli The use of artificial intelligence (‘AI’) systems in the pharmaceutical and healthcare sectors is growing exponentially, with...
06 Oct, 2023 Poland - Life Sciences Monthly Brief, September 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our September monthly briefing for Poland, which covers key updates and insights in the following areas: Medicinal...
29 Aug, 2023 Going green, literally – (slow) legalization of cannabis in Germany By Philip Weyand Guido Kleve Dylan Kennett Cannabis for adult-use is no longer a clandestine indulgence anymore, but a thriving industry in certain countries globally. Germany...
28 Apr, 2023 The UK voluntary scheme for branded medicines pricing and access (VPAS): just what the doctor ordered, or a bitter pill to swallow? By Michael Stead Martha Pownall On the 1 April this year, amidst storm clouds gathering above the NHS in the form of staffing strikes, record waiting times and chronic...
25 Apr, 2023 The Czech government is planning a regulated cannabis market By Jan Metelka Dylan Kennett The Czech government has announced its plan to introduce a highly regulated cannabis market in the Czech Republic. Currently, cannabis is...
20 Apr, 2023 Cross-border considerations for privacy in clinical trials - At the Intersection of Sciences and Law Podcast Series By James Clark Paula Gonzalez de Castejón Llano-Ponte David Kopans In this episode of At the Intersection of Sciences and Law Podcast Series, in light of the recent publication of our Cross-border Guide...
17 Apr, 2023 Plausibility of inventions: the decision of the EPO Enlarged Board of Appeal in G 2/21 By Massimiliano Tiberio Introduction On March 23rd, 2023, the Enlarged Board of Appeal of the EPO issued the long-awaited decision concerning the concept of...